We are live on ! Find out more
MJP

Michael J. Puzo Portfolio holdings

AUM $343M
1-Year Est. Return 18.42%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+18.42%
3 Year Est. Return
+60.27%
5 Year Est. Return
+82.68%
10 Year Est. Return
+283.93%
AUM
$361M
AUM Growth
+$45.9M
Cap. Flow
+$17.7M
Cap. Flow %
4.91%
Top 10 Hldgs %
40.06%
Holding
78
New
3
Increased
35
Reduced
27
Closed
3

Top Buys

Rank Stock Value
1
BALL icon
Ball Corp
BALL
+$1.82M
2
CARR icon
Carrier Global
CARR
+$1.81M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.59M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.12M
5
AMZN icon
Amazon
AMZN
+$959K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$3.05M
2
CVS icon
CVS Health
CVS
+$1.13M
3
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$594K
4
NVDA icon
NVIDIA
NVDA
+$400K
5
HON icon
Honeywell
HON
+$369K

Sector Composition

Rank Sector Weight
1 Technology 28.47%
2 Healthcare 21.49%
3 Industrials 12.76%
4 Consumer Discretionary 10.34%
5 Financials 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XOM icon
26
ExxonMobil
XOM
$638B
$4.61M 1.28%
39,629
+3,498
+10% +$366K
MDT icon
27
Medtronic
MDT
$112B
$4.44M 1.23%
50,923
+3,019
+6% +$258K
NKE icon
28
Nike
NKE
$63.5B
$4.4M 1.22%
46,845
+4,779
+11% +$486K
PEP icon
29
PepsiCo
PEP
$196B
$3.44M 0.95%
19,639
+1,749
+10% +$294K
NVS icon
30
Novartis
NVS
$304B
$3.37M 0.93%
34,810
-29,702
-46% -$3.05M
MRK icon
31
Merck
MRK
$328B
$2.81M 0.78%
21,310
-940
-4% -$116K
BRK.B icon
32
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.22M 0.61%
5,275
+875
+20% +$344K
ABBV icon
33
AbbVie
ABBV
$468B
$2.02M 0.56%
11,069
-55
-0.5% -$9.48K
BALL icon
34
Ball Corp
BALL
$17.8B
$2.01M 0.56%
+29,868
New +$1.82M
VRTX icon
35
Vertex Pharmaceuticals
VRTX
$124B
$1.93M 0.53%
4,613
+3,763
+443% +$1.59M
CARR icon
36
Carrier Global
CARR
$55.1B
$1.87M 0.52%
+32,143
New +$1.81M
APTV icon
37
Aptiv
APTV
$12.4B
$1.56M 0.43%
19,620
+2,865
+17% +$231K
CVS icon
38
CVS Health
CVS
$138B
$1.49M 0.41%
18,710
-14,784
-44% -$1.13M
INTC icon
39
Intel
INTC
$435B
$1.33M 0.37%
30,170
-610
-2% -$27.2K
MKC icon
40
McCormick & Company Non-Voting
MKC
$13.8B
$1.26M 0.35%
16,350
-3,450
-17% -$234K
CAT icon
41
Caterpillar
CAT
$383B
$1.15M 0.32%
3,150
-250
-7% -$79.9K
EMR icon
42
Emerson Electric
EMR
$84.9B
$1.15M 0.32%
10,117
-135
-1% -$13.9K
WMT icon
43
Walmart Inc
WMT
$913B
$957K 0.27%
+15,897
New +$910K
LLY icon
44
Eli Lilly
LLY
$1.09T
$856K 0.24%
1,100
-175
-14% -$125K
V icon
45
Visa
V
$698B
$833K 0.23%
2,985
-225
-7% -$62.1K
ASML icon
46
ASML
ASML
$605B
$752K 0.21%
775
+15
+2% +$13.3K
SHEL icon
47
Shell
SHEL
$239B
$721K 0.2%
10,750
-3,500
-25% -$224K
DE icon
48
Deere & Co
DE
$171B
$709K 0.2%
1,726
-55
-3% -$21.1K
NVO
49
Novo Nordisk
NVO
$225B
$655K 0.18%
5,100
-600
-11% -$71.4K
UNP icon
50
Union Pacific
UNP
$178B
$654K 0.18%
2,660
-400
-13% -$98.4K
1
2
3

Similar funds

WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
LWM
Long Walk Management Greenwich, Connecticut $344M AUM 44.86% 1-Year Est. Return
CWM
Cedar Wealth Management Walnut Creek, California $344M AUM 18.78% 1-Year Est. Return
BA
Ballast Advisors Woodbury, Minnesota $344M AUM 16.81% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return
SMG
Smart Money Group Eastland, Texas $344M AUM 16.66% 1-Year Est. Return
FMB
Field & Main Bank Henderson, Kentucky $344M AUM 23.98% 1-Year Est. Return
LKIM
Lawson Kroeker Investment Management Omaha, Nebraska $343M AUM 17.29% 1-Year Est. Return

Michael J. Puzo's Q1 2024 Portfolio in Review

As of Q1 2024, Michael J. Puzo held 78 positions worth $361M, up 15% from $315M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Michael J. Puzo deployed $17.7M of net new capital in Q1 2024, opening 3 new positions and adding to 35 existing holdings. Its largest new stake was Ball Corp: 29,868 shares worth $2.01M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Novartis, an estimated $3.05M trimmed.

  • Michael J. Puzo's largest Q1 2024 buy was Ball Corp: 29,868 shares worth $2.01M.
  • Michael J. Puzo added most to Vertex Pharmaceuticals in Q1 2024, an estimated $1.59M increase.
  • Michael J. Puzo's biggest Q1 2024 reduction was Novartis, cutting an estimated $3.05M.
  • Michael J. Puzo fully exited Pfizer in Q1 2024, selling an estimated $367K.
  • Michael J. Puzo's ten largest holdings make up 40% of its $361M portfolio in Q1 2024.
  • Michael J. Puzo opened 3 new positions and closed 3 in Q1 2024.
  • Michael J. Puzo's portfolio value rose 15% quarter-over-quarter to $361M.

Based on Michael J. Puzo's 13F filing for Q1 2024, filed 13 May 2024.